Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0001209191-15-053752

Director sold 250,000 shares at an average $26.68 ($6,670,678)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Troendle August J. Director 2015-06-12 Sale −134,167 $26.72 $3,585,251 2,008,325 I: show line 1 in the form
Troendle August J. Director 2015-06-12 Sale −1,851 $27.29 $50,512 2,006,474 I: show line 2 in the form
Troendle August J. Director 2015-06-15 Sale −111,606 $26.62 $2,970,583 1,894,868 I: show line 3 in the form
Troendle August J. Director 2015-06-15 Sale −2,376 $27.08 $64,331 1,892,492 I: show line 4 in the form
Open-market sales · 250,000 sh · avg $26.68 · $6,670,678
Loading xslF345X03/doc4.xml…